The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria
Open accessAbstract
Biological synthesis of nanoparticles is a growing innovative approach that is relatively cheaper and more environmentally friendly than current physicochemical processes. Among various microorganisms, fungi have been found to be comparatively more efficient in the synthesis of nanomaterials. In this research work, extracellular mycosynthesis of silver nanoparticles (AgNPs) was probed by reacting the precursor salt of silver nitrate (AgNO3) with culture filtrate of Aspergillus flavus. Initially, the mycosynthesis was regularly monitored by ultraviolet-visible spectroscopy, which showed AgNP peaks of around 400-470 nm. X-ray diffraction spectra revealed peaks of different intensities with respect to angle of diffractions (2θ) corresponding to varying configurations of AgNPs. Transmission electron micrographs further confirmed the formation of AgNPs in size ranging from 5-30 nm. Combined and individual antibacterial activities of the five conventional antibiotics and AgNPs were investigated against eight different multidrug-resistant bacterial species using the Kirby-Bauer disk-diffusion method. The decreasing order of antibacterial activity (zone of inhibition in mm) of antibiotics, AgNPs, and their conjugates against bacterial group (average) was; ciprofloxacin + AgNPs (23) . imipenem + AgNPs (21) > gentamycin + AgNPs (19) > vancomycin + AgNPs (16) > AgNPs (15) . imipenem (14) > trimethoprim + AgNPs (14) > ciprofloxacin (13) > gentamycin (11) > vancomycin (4) > trimethoprim (0). Overall, the synergistic effect of antibiotics and nanoparticles resulted in a 0.2-7.0 (average, 2.8) fold-area increase in antibacterial activity, which clearly revealed that nanoparticles can be effectively used in combination with antibiotics in order to improve their efficacy against various pathogenic microbes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Nanosilver — The burgeoning therapeutic molecule and its green synthesis
Vaidyanathan, R., Kalishwaralal, K., Gopalram, S., & Gurunathan, S. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.08.001 · Cited by 243
RetractedSondi, I., & Salopek-Sondi, B. (2004) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.02.012 · Cited by 5,986
Antimicrobial effects of silver nanoparticles
Kim, J. S., Kuk, E., Yu, K. N., Kim, J.-H., Park, S. J., Lee, H. J., Kim, S. H., Park, Y. K., Park, Y. H., Hwang, C.-Y., et al. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.12.001 · Cited by 4,918
Surface Plasmon Spectroscopy of Nanosized Metal Particles
Mulvaney, P. (1996) · Langmuir · doi:10.1021/la9502711 · Cited by 3,681
Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum
Ahmad, A., Mukherjee, P., Senapati, S., Mandal, D., Khan, M. I., Kumar, R., & Sastry, M. (2003) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(02)00174-1 · Cited by 1,976
Rai, M. K., Deshmukh, S. D., Ingle, A. P., & Gade, A. K. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05253.x · Cited by 1,524
Mukherjee, P., Ahmad, A., Mandal, D., Senapati, S., Sainkar, S. R., Khan, M. I., Parishcha, R., Ajaykumar, P. V., Alam, M., Kumar, R., et al. (2001) · Nano Letters · doi:10.1021/nl0155274 · Cited by 1,438
Fayaz, A. M., Balaji, K., Girilal, M., Yadav, R., Kalaichelvan, P. T., & Venketesan, R. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.006 · Cited by 1,417
Dahl, J. A., Maddux, B. L. S., & Hutchison, J. E. (2007) · Chemical Reviews · doi:10.1021/cr050943k · Cited by 1,284
Biosynthesis of Nanoparticles by Microorganisms and Their Applications
Li, X., Xu, H., Chen, Z.-S., & Chen, G. (2011) · Journal of Nanomaterials · doi:10.1155/2011/270974 · Cited by 1,133
Cited by
Silver Nanoparticles as Potential Antibacterial Agents
Franci, G., Falanga, A., Galdiero, S., Palomba, L., Rai, M., Morelli, G., & Galdiero, M. (2015) · Molecules · doi:10.3390/molecules20058856 · Cited by 1,674
A review on green synthesis of silver nanoparticles and their applications
Rafique, M., Sadaf, I., Rafique, M. S., & Tahir, M. B. (2017) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2016.1241792 · Cited by 941
Synthesis of Silver Nanoparticles Mediated by Fungi: A Review
Guilger-Casagrande, M., & Lima, R. D. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00287 · Cited by 712
Nanomaterials for alternative antibacterial therapy
Hemeg, H. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s132163 · Cited by 550
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
Lee, N.-Y., Ko, W.-C., & Hsueh, P.-R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01153 · Cited by 532
Similarities and Differences between Silver Ions and Silver in Nanoforms as Antibacterial Agents
Kędziora, A., Speruda, M., Krzyżewska, E., Rybka, J., Łukowiak, A., & Bugla-Płoskońska, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020444 · Cited by 452
Current applications of nanoparticles in infectious diseases
Zazo, H., Colino, C. I., & Lanao, J. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.008 · Cited by 434
A repertoire of biomedical applications of noble metal nanoparticles
Azharuddin, M., Zhu, G. H., Das, D., Ozgur, E., Uzun, L., Turner, A. P. F., & Patra, H. K. (2019) · Chemical Communications · doi:10.1039/c9cc01741k · Cited by 395
Patra, J. K., & Baek, K.-H. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00167 · Cited by 327
Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options
Chatterjee, M., Anju, C. P., Biswas, L., Anil Kumar, V., Gopi Mohan, C., & Biswas, R. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2015.11.004 · Cited by 312
Strategic role of selected noble metal nanoparticles in medicine
Rai, M., Ingle, A. P., Birla, S., Yadav, A., & Santos, C. A. D. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1018131 · Cited by 290
Recent Developments in Methicillin-Resistant Staphylococcus aureus (MRSA) Treatment: A Review
Nandhini, P., Kumar, P., Mickymaray, S., Alothaim, A. S., Somasundaram, J., & Rajan, M. (2022) · Antibiotics · doi:10.3390/antibiotics11050606 · Cited by 289
Luo, J., Zhang, Q., Zhao, J., Wu, Y., Wu, L., Li, H., Tang, M., Sun, Y., Guo, W., Feng, Q., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121176 · Cited by 286
Noga, M., Milan, J., Frydrych, A., & Jurowski, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065133 · Cited by 284
Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A Review
Ribeiro, A. I., Dias, A. M., & Zille, A. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c03891 · Cited by 276
León-Buitimea, A., Garza-Cárdenas, C. R., Garza-Cervantes, J. A., Lerma-Escalera, J. A., & Morones-Ramírez, J. R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01669 · Cited by 274
Singh, P., Singh, H., Kim, Y. J., Mathiyalagan, R., Wang, C., & Yang, D. C. (2016) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2016.02.005 · Cited by 189
Metadata
- Authors
- Naqvi, S. Z., Kiran, U., Ali, Jamal, Hameed, Ahmed, & Ali
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2013-08
- Volume
- 8
- Pages
- 3187
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W1976544480
- Cited by
- 299
- References
- 37
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.